nani
|
| Wed Feb 08, 2006 10:00 pm THREE PATIENTS WITH MULTIPLE SCLEROSIS (MS) SHOW FAVORABLE R |
|
|
Las Vegas, Nevada 2/7/2006 10:58 PM GMT (TransWorldNews)
Las Vegas (Transworldnew.com) Tuesday, February 07, 2006
Three MS patients, all wheelchair bound, have reported the following results 4-6 days after the stem cell / placenta implant
1. Cold feet needing various forms of heating during the night become warm with no need of heating.
2. Substantial improvement or disappearance of spasticity.
3. Being able, while in the wheelchair, to move their legs with relative ease.
4. Urinary frequency markedly reduced.
STEMCELL PHARMA, Inc. is a biotechnology/pharmaceutical corporation that has acquired world wide rights of a proprietary technology titled: Amnion Stem Cells Telomerase Enhanced Placenta Implant. The Implant that had shown promising preliminary results in certain conditions including Multiple Sclerosis (MS) also in symptoms and diseases associated with aging.
While the initial purpose of Stem Cell Pharma was to apply to the Nevada legislators to approve a Stem Cell clinic in Las Vegas, presently obtained results might encourage us to change strategy and apply to the FDA for approval to start certain clinical trials. In the meantime Nevada physicians are carrying out “the Implant” procedure in their offices and private practices, and the results obtained might be used for future FDA endeavors.
In a following news release certain non-confidential information regarding “the Implant” will be released that will show that this technique is entirely different from the stem cell techniques used elsewhere.
For more information please contact:
Alfred T. Sapse MD (ret) c/o Stem Cell Pharma Inc., Las Vegas, NV
Phone: (702) 383-5892 Fax: (702) 733-9505 |
|
